Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5419451

O=C(CCC(=O)N1CCc2ccccc2C1)c1ccc2c(c1)CCNCC2.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 5/20 0.52
ACHE P22303 1/20 0.51
HPGD P15428 2/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
DPP4 P27487 1/20 0.45
DPP8 Q6V1X1 1/20 0.45
DPP7 Q9UHL4 1/20 0.45
GAA P10253 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
ALDH1A1 P00352 3/20 0.44
CTNNB1 P35222 1/20 0.42
WNT3A P56704 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14489792 0.93 MCHR1 (0.59) MCHR1ACHEHPGDTSHRSMN1; SMN2
Trifluoroacetic Acid SCHEMBL5422955 0.85 MCHR1 (0.58) MCHR1ACHESMN1; SMN2CTNNB1WNT3A
Trifluoroacetic Acid SCHEMBL5422589 0.85 MCHR1 (0.54) MCHR1ACHEHPGDSMN1; SMN2HSD17B10
Trifluoroacetic Acid SCHEMBL5428807 0.84 MCHR1 (0.56) MCHR1ACHEHPGDSMN1; SMN2HSD17B10
Trifluoroacetic Acid SCHEMBL5422928 0.83 ACHE (0.66) MCHR1ACHEDPP8DPP7
Trifluoroacetic Acid SCHEMBL6802930 0.83 DRD2 (0.62) MCHR1ACHEHPGDHSD17B10ALDH1A1
Trifluoroacetic Acid SCHEMBL5427534 0.83 MCHR1 (0.63) MCHR1ACHESMN1; SMN2CTNNB1WNT3A
Trifluoroacetic Acid SCHEMBL5427262 0.83 MCHR1 (0.52) MCHR1ACHEDPP8DPP7ALDH1A1
Trifluoroacetic Acid SCHEMBL5416228 0.82 MCHR1 (0.55) MCHR1ACHESMN1; SMN2ALDH1A1CTNNB1
Trifluoroacetic Acid SCHEMBL5427286 0.82 MCHR1 (0.55) MCHR1ACHESMN1; SMN2ALDH1A1CTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229986-B2 Melanin-concentrating hormone antagonist TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2007-06-12 US disclosed
US-20030158177-A1 Treating or preventing obesity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-08-21 US disclosed
EP-1283199-A1 MELANIN-CONCENTRATING HORMONE ANTAGONIST Takeda Chemical Industries, Ltd. (JP) 2003-02-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158177-A1 Treating or preventing obesity MCHR1, MC1R, NPY1R MCHR1 1/4885ACHE 4544/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.